- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Infliximab – March 2014
Infliximab, 100 mg injection, 1 x 100 mg vial, Remicade®
Last updated
8 November 2023